HRS is hosting a Twitter Chat on Wednesday, November 9 from 5-6 p.m. ET.
Search for "" returned 66 matches
HRS is hosting a Twitter Chat on Tuesday, January 31 at 4 p.m. ET.
HRS is hosting a Twitter Chat on Tuesday, February 14 at 12 p.m. ET.
HRS is hosting a Twitter Chat on Thursday, June 29 from 12-1 p.m. ET.
HRS is hosting a Twitter Chat on Wednesday, September 20 from 4-5 p.m. ET
In November 2014, the Heart Rhythm Society (HRS) and National Stroke Association, in collaboration with Boehringer Ingelheim (BI), shared results from a survey of more than 1,200 respondents to evaluate the impact of AFib and stroke on patients and caregivers, and the concurrent perceptions physicians have about treatment options and their patients’ understanding of issues surrounding the condition.
Today, the Heart Rhythm Society (HRS) in joint partnership with the European Heart Rhythm Association (EHRA), European Cardiac Arrhythmia Society (ECAS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) issued an international consensus statement that provides a state-of-the-art review of the indications, techniques, and outcomes of catheter and surgical ablation of atrial fibrillation (AF). The 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, first issued in 2007, and again in 2012, represents a state-of-the art review of the field of catheter and surgical ablation of AF. This document is a complete and comprehensive revision of the 2012 statement and was presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.
Atrial fibrillation (AFib) is an abnormal heart rhythm. The four chambers of the heart usually beat in a steady, rhythmic pattern. AFib means that the atria (upper chambers of the heart) are fibrillating or twitching quickly and creating an irregular rhythm.
The Heart Rhythm Society (HRS), through its efforts during Atrial Fibrillation Awareness Month in September and throughout the year, is working to increase public knowledge of AFib, including its symptoms, warning signs, and available treatment options.
The Heart Rhythm Society endorsed the document on May 30, 2017.
July 5, 2017—Atrial fibrillation (AF) is the most common cardiac arrhythmia, occurring in 1–2% of the general population. An earlier detection of AF could allow an earlier adequate management to avoid later complications. Screening for AF is not yet recommended by all scientific AF guidelines, even in specific at-risk populations. This document summarizes the available data, discusses the different strategies, and highlights the importance of implicating all stakeholders from the various health systems.